Technical Analysis for RVPH - Reviva Pharmaceuticals Holdings, Inc.

Grade Last Price % Change Price Change
D 1.22 -3.57% -0.05
RVPH closed down 3.57 percent on Wednesday, November 20, 2024, on 56 percent of normal volume. It was able to find support at its 50 day moving average.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Flat Up

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
50 DMA Support Bullish -3.57%
MACD Bullish Centerline Cross Bullish -3.57%
Calm After Storm Range Contraction -3.57%
Wide Bands Range Expansion -3.57%
Upper Bollinger Band Touch Strength -3.57%
Crossed Above 20 DMA Bullish -4.33%
Crossed Above 50 DMA Bullish -4.33%

   Recent Intraday Alerts

Alert Time
Down 5% about 15 hours ago
Fell Below Previous Day's Low about 15 hours ago
50 DMA Support about 17 hours ago
60 Minute Opening Range Breakdown about 17 hours ago
Possible NR7 about 17 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Reviva Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops therapies to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Its lead product candidate is RP5063 for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, as well as for treating pulmonary arterial hypertension and idiopathic pulmonary fibrosis. The company is based in Cupertino, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Drugs Inflammatory Diseases Schizophrenia Psychiatric Diagnosis Psychiatry Major Depressive Disorder Stage Pharmaceutical Idiopathic Pulmonary Fibrosis Pulmonary Arterial Hypertension Pulmonary Fibrosis Chloroarenes Bipolar Disorder Pulmonary Hypertension Treatment Of Schizophrenia Piperazines

Is RVPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.66
52 Week Low 0.6
Average Volume 452,239
200-Day Moving Average 1.97
50-Day Moving Average 1.21
20-Day Moving Average 1.11
10-Day Moving Average 1.15
Average True Range 0.15
RSI (14) 52.83
ADX 20.82
+DI 24.90
-DI 15.45
Chandelier Exit (Long, 3 ATRs) 1.03
Chandelier Exit (Short, 3 ATRs) 1.34
Upper Bollinger Bands 1.37
Lower Bollinger Band 0.86
Percent B (%b) 0.7
BandWidth 45.82
MACD Line 0.01
MACD Signal Line -0.02
MACD Histogram 0.0263
Fundamentals Value
Market Cap 33.92 Million
Num Shares 27.9 Million
EPS -1.68
Price-to-Earnings (P/E) Ratio -0.72
Price-to-Sales 0.00
Price-to-Book 69.86
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.38
Resistance 3 (R3) 1.39 1.35 1.35
Resistance 2 (R2) 1.35 1.30 1.34 1.34
Resistance 1 (R1) 1.28 1.28 1.26 1.27 1.33
Pivot Point 1.24 1.24 1.22 1.23 1.24
Support 1 (S1) 1.17 1.19 1.15 1.16 1.10
Support 2 (S2) 1.13 1.17 1.12 1.09
Support 3 (S3) 1.06 1.13 1.08
Support 4 (S4) 1.05